Home » Topics » Regulatory

Regulatory
RSS

RPR's enoxaparin reduces risk of DVT following hip replacement

Aug. 9, 1996

Biovail's diltiazem covered under U.S. patent

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Lidocaine nasal drops shown effective for fast migraine pain relief

Aug. 9, 1996

Actiq to undergo phase III clinical trials

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...